| 【英語タイトル】Global Autotransfusion Devices Market Size study & Forecast, by Product Type (Autotransfusion Systems and Consumables & Accessories), By Application (Cardiovascular Surgeries, Orthopedic Surgeries, Neurological Surgeries, Obstetrics & Gynecological Surgeries), By End-User (Hospitals and Specialty Clinics) and Regional Analysis, 2022-2029
|
 | ・商品コード：BZW23FB128
・発行会社（調査会社）：Bizwit Research & Consulting
・発行日：2023年1月25日
・ページ数：約200
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後3営業日）
・調査対象地域：アメリカ、カナダ、イギリス、ドイツ、フランス、スペイン、イタリア、中国、インド、日本、オーストラリア、韓国、ブラジル、メキシコ、中東
・産業分野：医療
|
◆販売価格オプション
（消費税別）
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
|
❖ レポートの概要 ❖
Bizwit Research社の本調査レポートは、2021年にXXX億ドルであった世界の自動輸血装置市場規模が、2022年から2029年の間にXXX%成長すると予想しています。本レポートでは、自動輸血装置の世界市場について調査し、エグゼクティブサマリー、市場定義・範囲、市場動向、産業分析、リスク分析（新型コロナウイルス感染症の影響）、製品種類別（自動輸血装置、消耗品＆付属品）分析、用途別（心臓血管外科、整形外科、神経外科、産科＆婦人科外科）分析、エンドユーザー別（病院、専門クリニック）分析、地域別（北米、ヨーロッパ、アジア太平洋、中南米、その他）分析、競争状況、調査プロセスなどの項目を掲載しています。また、本書には、LivaNovaPLC(U.K.)、Medtronic(Ireland)、HaematonicsCorporation(U.S.)、FreseniusSE&Co.KGaA(Germany)、BD(Becton,Dickinson,andCompany)(U.S.)、BeijingJingjingMedicalEquipmentCo.,Ltd.(China)、ProCellSurgicalInc.(U.S.)、TeleflexIncorporated(US)、AtriumMedicalCorporation(US)、SARSTEDTCorporation(Germany)などの企業情報が含まれています。
・エグゼクティブサマリー
・市場定義・範囲
・市場動向
・産業分析
・リスク分析（新型コロナウイルス感染症の影響）
・世界の自動輸血装置市場規模：製品種類別
- 自動輸血装置の市場規模
- 消耗品＆付属品の市場規模
・世界の自動輸血装置市場規模：用途別
- 心臓血管外科における市場規模
- 整形外科における市場規模
- 神経外科における市場規模
- 産科＆婦人科外科における市場規模
・世界の自動輸血装置市場規模：エンドユーザー別
- 病院における市場規模
- 専門クリニックにおける市場規模
・世界の自動輸血装置市場規模：地域別
- 北米の自動輸血装置市場規模
- ヨーロッパの自動輸血装置市場規模
- アジア太平洋の自動輸血装置市場規模
- 南米の自動輸血装置市場規模
- その他地域の自動輸血装置市場規模
・競争状況
・調査プロセス |
Global Autotransfusion Devices Market is valued approximately USD XXX billion in 2021 and is anticipated to grow with a healthy growth rate of more than XXX% over the forecast period 2022-2029. Autotransfusion devices are commonly used to collect and reinfuse the patient’s blood. The use of autologous blood transfusions to prevent infections brought on by allogeneic blood transfusions is made possible by these systems, that play a key role in cell salvage techniques. These devices are used in invasive procedures for the heart, the joints, the nervous system, obstetrics, and gynecologist. Systems can be divided into intraoperative systems, post-operative systems, and dual-mode systems. The key factor driving the market growth is rising number of surgical procedures, rising prevalence of cardiovascular diseases, and scarcity of donated blood/allogenic blood. Thus, create the lucrative demand for the market during forecast period.
Blood transfusions and Intraoperative & postoperative cell salvage are essential parts of blood conservation during any surgical treatment. A growing number of high-bleeding surgeries and the emphasis on avoiding problems from allogeneic transfusions are also anticipated to fuel the growth of the global market over the forecast period. According to, The American Academy of Orthopaedic Surgeons (AAOS) and the Agency for Healthcare Research and Quality (AHRQ) estimate that every year in the United States, approximately 700,000 knee replacement procedures and about 450,000 hip replacement procedures are performed. The University of Alabama revealed in a 2021 article that 320,000 coronary artery bypass grafting surgeries were carried out in the United States year 2020. Additionally, rising technological advancement in the autotransfusion system would create the lucrative opportunity for the market during forecast period. However, the lack of skilled technicians for handling the autotransfusion system stifles market growth throughout the forecast period of 2022-2029.
The key regions considered for the Global Autotransfusion Devices Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America is the dominating region across the world in terms of market share, owing to the better health care infrastructure and facilities, increasing number of patient suffering from orthopedic diseases, cardiovascular diseases, and increase in geriatric population. Whereas, Asia Pacific is also anticipated to exhibit highest growth rate over the forecast period, owing to factors such as rising number of surgical procedures and growing investment on the developing healthcare infrastructure would create lucrative growth prospects for the Autotransfusion Devices market across Asia Pacific region.
Major market player included in this report are:
LivaNova PLC (U.K.)
Medtronic (Ireland)
Haematonics Corporation (U.S.)
Fresenius SE & Co. KGaA (Germany)
BD (Becton, Dickinson, and Company) (U.S.)
Beijing Jingjing Medical Equipment Co., Ltd. (China)
ProCell Surgical Inc. (U.S.)
Teleflex Incorporated (US)
Atrium Medical Corporation (US)
SARSTEDT Corporation (Germany)
Recent Developments in the Market:
In 2020, ProCell Surgical Inc. launched the ProCell, its first medical device developed to efficiently automate the manual and obsolete activity of surgical sponge-blood recovering for intraoperative autotransfusion.
Global Autotransfusion Devices Market Report Scope:
Historical Data 2019-2020-2021
Base Year for Estimation 2021
Forecast period 2022-2029
Report Coverage Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered Product Type, Application, End-User, Region
Regional Scope North America; Europe; Asia Pacific; Latin America; Rest of the World
Customization Scope Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.
The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Product Type:
Autotransfusion Systems
Consumables & Accessories
By Application:
Cardiovascular Surgeries
Orthopedic Surgeries
Neurological Surgeries
Obstetrics & Gynecological Surgeries
By End-User:
Hospitals
Specialty Clinics
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
RoLA
Rest of the World
Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
1.2.1. Autotransfusion Devices Market, by Region, 2019-2029 (USD Billion)
1.2.2. Autotransfusion Devices Market, by Product Type, 2019-2029 (USD Billion)
1.2.3. Autotransfusion Devices Market, by Application, 2019-2029 (USD Billion)
1.2.4. Autotransfusion Devices Market, by End-User, 2019-2029 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Autotransfusion Devices Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Autotransfusion Devices Market Dynamics
3.1. Autotransfusion Devices Market Impact Analysis (2019-2029)
3.1.1. Market Drivers
3.1.1.1. Rising number of surgical procedures
3.1.1.2. Growing prevalence of cardiovascular diseases
3.1.2. Market Challenges
3.1.2.1. Lack of skilled technicians for handling the autotransfusion system
3.1.3. Market Opportunities
3.1.3.1. Rising technological advancement in the autotransfusion system
Chapter 4. Global Autotransfusion Devices Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Futuristic Approach to Porter’s 5 Force Model (2019-2029)
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. Industry Experts Prospective
4.7. Analyst Recommendation & Conclusion
Chapter 5. Risk Assessment: COVID-19 Impact
5.1. Assessment of the overall impact of COVID-19 on the industry
5.2. Pre COVID-19 and post COVID-19 Market scenario
Chapter 6. Global Autotransfusion Devices Market, by Product Type
6.1. Market Snapshot
6.2. Global Autotransfusion Devices Market by Product Type, Performance – Potential Analysis
6.3. Global Autotransfusion Devices Market Estimates & Forecasts by Product Type 2019-2029 (USD Billion)
6.4. Autotransfusion Devices Market, Sub Segment Analysis
6.4.1. Autotransfusion Systems
6.4.2. Consumables & Accessories
Chapter 7. Global Autotransfusion Devices Market, by Application
7.1. Market Snapshot
7.2. Global Autotransfusion Devices Market by Application, Performance – Potential Analysis
7.3. Global Autotransfusion Devices Market Estimates & Forecasts by Application 2019-2029 (USD Billion)
7.4. Autotransfusion Devices Market, Sub Segment Analysis
7.4.1. Cardiovascular Surgeries
7.4.2. Orthopedic Surgeries
7.4.3. Neurological Surgeries
7.4.4. Obstetrics & Gynecological Surgeries
Chapter 8. Global Autotransfusion Devices Market, by End-User
8.1. Market Snapshot
8.2. Global Autotransfusion Devices Market by End-User, Performance – Potential Analysis
8.3. Global Autotransfusion Devices Market Estimates & Forecasts by End-User 2019-2029 (USD Billion)
8.4. Autotransfusion Devices Market, Sub Segment Analysis
8.4.1. Hospitals
8.4.2. Specialty Clinics
Chapter 9. Global Autotransfusion Devices Market, Regional Analysis
9.1. Autotransfusion Devices Market, Regional Market Snapshot
9.2. North America Autotransfusion Devices Market
9.2.1. U.S. Autotransfusion Devices Market
9.2.1.1. Product Type breakdown estimates & forecasts, 2019-2029
9.2.1.2. Application breakdown estimates & forecasts, 2019-2029
9.2.1.3. End-User breakdown estimates & forecasts, 2019-2029
9.2.2. Canada Autotransfusion Devices Market
9.3. Europe Autotransfusion Devices Market Snapshot
9.3.1. U.K. Autotransfusion Devices Market
9.3.2. Germany Autotransfusion Devices Market
9.3.3. France Autotransfusion Devices Market
9.3.4. Spain Autotransfusion Devices Market
9.3.5. Italy Autotransfusion Devices Market
9.3.6. Rest of Europe Autotransfusion Devices Market
9.4. Asia-Pacific Autotransfusion Devices Market Snapshot
9.4.1. China Autotransfusion Devices Market
9.4.2. India Autotransfusion Devices Market
9.4.3. Japan Autotransfusion Devices Market
9.4.4. Australia Autotransfusion Devices Market
9.4.5. South Korea Autotransfusion Devices Market
9.4.6. Rest of Asia Pacific Autotransfusion Devices Market
9.5. Latin America Autotransfusion Devices Market Snapshot
9.5.1. Brazil Autotransfusion Devices Market
9.5.2. Mexico Autotransfusion Devices Market
9.5.3. Rest of Latin America Autotransfusion Devices Market
9.6. Rest of The World Autotransfusion Devices Market
Chapter 10. Competitive Intelligence
10.1. Top Market Strategies
10.2. Company Profiles
10.2.1. LivaNova PLC (U.K.)
10.2.1.1. Key Information
10.2.1.2. Overview
10.2.1.3. Financial (Subject to Data Availability)
10.2.1.4. Product Summary
10.2.1.5. Recent Developments
10.2.2. Medtronic (Ireland)
10.2.3. Haematonics Corporation (U.S.)
10.2.4. Fresenius SE & Co. KGaA (Germany)
10.2.5. BD (Becton, Dickinson, and Company) (U.S.)
10.2.6. Beijing Jingjing Medical Equipment Co., Ltd. (China)
10.2.7. ProCell Surgical Inc. (U.S.)
10.2.8. Teleflex Incorporated (US)
10.2.9. Atrium Medical Corporation (US)
10.2.10. SARSTEDT Corporation (Germany)
Chapter 11. Research Process
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes
11.3. Research Assumption
